Skills for Talking About Cannabis for Families of Young Adults With Psychosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Washington
About this trial
The objectives of this research is to (1) create a family intervention and provider manual to train family members of young people with psychosis (YP-P) who are heavy cannabis users new communication skills to motivate change in the YP-P's cannabis use, (2) pre-test the intervention with 10 family member participants and adapt the intervention based on their recommendations, and (3) evaluate the feasibility and acceptability of the intervention in a randomized pilot trial (n=40). The investigators anticipate that the intervention will improve family participants' communication skills, decrease expressed emotion and caregiver burden. The investigators anticipate that improvements in communication skills, expressed emotion and caregiver burden will lead to decreases in the cannabis use of their YP-P.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
aged 18 years or older,
has a loved one who is both in CSC treatment for FEP and has used cannabis in the past 30 days,
has regular contact with their loved one with FEP. It is assumed that YA-P will be aged 13-40 with schizophrenia spectrum disorder given criteria for CSC enrollment.
Disqualifiers
Unable to read study materials and communicate feedback in English
Do not have access to Zoom
Trial design
Design model
Parallel
Treatments tested in this trial
Cannabis Conversation Skills for Families (CCSF)
BehavioralThe purpose of the intervention is to train family members in communication skills that may increase contemplation of change in their loved one with first episode psychosis to reduce cannabis use, decrease conflict surrounding these discussions, and provide skills to understand when and how to approach their loved one about cannabis use and encourage treatment. Because families report confusion from the mixed messages they receive about cannabis and also desire research-based information, CCSF will involve psychoeducation on the risks and relationship of cannabis to psychosis to increase participants motivation to engage in the intervention. frequency of cannabis use as it relates to psychosis treatment outcomes.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Cannabis Conversation Skills for Families (CCSF)Experimental treatment 1 intervention
Group B: Treatment as Usual (TAU) ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Cannabis and psychosis knowledge
Cannabis knowledge test. This measure does not use a scale; multiple choice items test understanding of cannabis products, consumption, and impacts. Higher scores indicate higher level of cannabis knowledge.
Time frame
baseline, 3 month follow-up2
Caregiver Burden Index
The CBI is a 24-item assessment of both objective (time away from work for caregiving) and subjective (psychological impact) burden of caregiving in a Likert-format scale (0-4) that measures five dimensions of caregiver burden: time dependence, developmental, physical, social, and emotional burden. Each sub scale ranges from 0 (low ) to 20 (high).
Time frame
baseline, 3 month follow-up3
Family Attitudes Scale (FAS)
The FAS is a 30-item self-report measure of expressed emotion (EE) using a Likert scale (e.g., 1 to 5); higher scores indicate more positive attitudes towards family dynamics, while lower scores suggests negative attitudes.
Time frame
baseline, 3 month follow-up4
Timeline Followback - Collateral version (TLFB-C)
The TLFB will ask participants to complete a calendar for the past 30 days indicating the days they believe their YA-P used cannabis and other substances.
Time frame
baseline, 3 month follow upSecondary outcomes
1
Client Satisfaction Questionnaire (CSQ-8)
Intervention satisfaction will be assessed with the CSQ-8, a widely used instrument, consisting of eight items each answered on a 4-point scale. The possible scores range from 8 to 32, with higher scores indicating a greater level of overall satisfaction with the services received.
Time frame
3 month follow upSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Washington
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: